“Patients With Anti-Small Ubiquitin-Like Modifier Activating Enzyme-Positive Dermatomyositis Resembling Antisynthetase Syndrome With Poor Prognosis: A Bicentric International Retrospective Study and Literature Review”. Reumatismo, vol. 77, no. 1, Oct. 2024, https://doi.org/10.4081/reumatismo.2024.1686.